1. Home
  2. TXNM vs BRKR Comparison

TXNM vs BRKR Comparison

Compare TXNM & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXNM
  • BRKR
  • Stock Information
  • Founded
  • TXNM 1917
  • BRKR 1960
  • Country
  • TXNM United States
  • BRKR United States
  • Employees
  • TXNM N/A
  • BRKR N/A
  • Industry
  • TXNM
  • BRKR Biotechnology: Laboratory Analytical Instruments
  • Sector
  • TXNM
  • BRKR Industrials
  • Exchange
  • TXNM NYSE
  • BRKR Nasdaq
  • Market Cap
  • TXNM 4.9B
  • BRKR 5.6B
  • IPO Year
  • TXNM N/A
  • BRKR 2000
  • Fundamental
  • Price
  • TXNM $56.43
  • BRKR $38.08
  • Analyst Decision
  • TXNM Buy
  • BRKR Buy
  • Analyst Count
  • TXNM 7
  • BRKR 12
  • Target Price
  • TXNM $54.86
  • BRKR $57.50
  • AVG Volume (30 Days)
  • TXNM 1.4M
  • BRKR 1.8M
  • Earning Date
  • TXNM 07-30-2025
  • BRKR 08-05-2025
  • Dividend Yield
  • TXNM 2.89%
  • BRKR 0.53%
  • EPS Growth
  • TXNM 144.40
  • BRKR N/A
  • EPS
  • TXNM 2.24
  • BRKR 0.52
  • Revenue
  • TXNM $2,017,114,000.00
  • BRKR $3,446,100,000.00
  • Revenue This Year
  • TXNM $10.59
  • BRKR $6.43
  • Revenue Next Year
  • TXNM $5.09
  • BRKR $4.21
  • P/E Ratio
  • TXNM $25.23
  • BRKR $72.54
  • Revenue Growth
  • TXNM 10.11
  • BRKR 14.84
  • 52 Week Low
  • TXNM $35.56
  • BRKR $34.10
  • 52 Week High
  • TXNM $57.29
  • BRKR $72.94
  • Technical
  • Relative Strength Index (RSI)
  • TXNM 57.98
  • BRKR 48.41
  • Support Level
  • TXNM $56.46
  • BRKR $37.15
  • Resistance Level
  • TXNM $56.87
  • BRKR $41.94
  • Average True Range (ATR)
  • TXNM 0.35
  • BRKR 1.45
  • MACD
  • TXNM -0.16
  • BRKR 0.06
  • Stochastic Oscillator
  • TXNM 18.06
  • BRKR 37.84

About TXNM TXNM ENERGY INC

TXNM Energy Inc is a holding company that owns regulated utility companies providing energy to houses and businesses across Texas and New Mexico using its utilities.

About BRKR Bruker Corporation

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Share on Social Networks: